1. Home
  2. GHI vs XOMA Comparison

GHI vs XOMA Comparison

Compare GHI & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHI
  • XOMA
  • Stock Information
  • Founded
  • GHI 1998
  • XOMA 1981
  • Country
  • GHI United States
  • XOMA United States
  • Employees
  • GHI N/A
  • XOMA N/A
  • Industry
  • GHI Finance: Consumer Services
  • XOMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GHI Finance
  • XOMA Health Care
  • Exchange
  • GHI Nasdaq
  • XOMA Nasdaq
  • Market Cap
  • GHI 285.3M
  • XOMA 250.1M
  • IPO Year
  • GHI N/A
  • XOMA N/A
  • Fundamental
  • Price
  • GHI $12.33
  • XOMA $19.93
  • Analyst Decision
  • GHI Strong Buy
  • XOMA Strong Buy
  • Analyst Count
  • GHI 3
  • XOMA 2
  • Target Price
  • GHI $16.50
  • XOMA $72.00
  • AVG Volume (30 Days)
  • GHI 43.5K
  • XOMA 29.3K
  • Earning Date
  • GHI 05-07-2025
  • XOMA 03-17-2025
  • Dividend Yield
  • GHI 12.01%
  • XOMA N/A
  • EPS Growth
  • GHI N/A
  • XOMA N/A
  • EPS
  • GHI 0.76
  • XOMA N/A
  • Revenue
  • GHI $32,275,700.00
  • XOMA $28,487,000.00
  • Revenue This Year
  • GHI $226.38
  • XOMA $29.60
  • Revenue Next Year
  • GHI N/A
  • XOMA $34.18
  • P/E Ratio
  • GHI $16.22
  • XOMA N/A
  • Revenue Growth
  • GHI N/A
  • XOMA 498.72
  • 52 Week Low
  • GHI $10.12
  • XOMA $19.79
  • 52 Week High
  • GHI $16.29
  • XOMA $35.00
  • Technical
  • Relative Strength Index (RSI)
  • GHI 41.88
  • XOMA 31.42
  • Support Level
  • GHI $12.44
  • XOMA $20.45
  • Resistance Level
  • GHI $13.10
  • XOMA $21.45
  • Average True Range (ATR)
  • GHI 0.32
  • XOMA 0.86
  • MACD
  • GHI -0.07
  • XOMA 0.11
  • Stochastic Oscillator
  • GHI 15.34
  • XOMA 6.67

About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: